ÂÜÀòÂÒÂ×

Rodriguez-Hervas’s appointment highlights the growing focus on AI within the pharmaceutical industry. With more than a decade of experience in AI, machine learning, and analytics, she is expected to play a pivotal role in advancing Pfizer’s AI capabilities. Lidia Fonseca, Pfizer’s Chief Digital and Technology Officer, expressed confidence in Rodriguez-Hervas’s ability to elevate the company’s AI strategies, citing her proven track record of rapidly developing and scaling AI solutions in global organizations.

Before joining Pfizer, Rodriguez-Hervas was Vice President of Artificial Intelligence, Algorithms, and Machine Learning Operations at Stellantis, an automotive company. There, she was responsible for designing and implementing strategies for the next generation of autonomous vehicles. Her expertise in AI is also demonstrated by her previous roles as a Senior Software Engineering Manager and Principal Scientist at NVIDIA, where she focused on computer vision and deep learning, and as a Machine Learning Manager at Tesla, where she contributed to advancements in Autopilot Computer Vision.

Rodriguez-Hervas’s diverse background in AI across various industries, including automotive and technology, positions her well to lead Pfizer’s AI initiatives. She holds a Ph.D. in Electrical and Computer Engineering from The University of Texas at El Paso, further solidifying her strong technical foundation.

In her new role, Rodriguez-Hervas is excited about the opportunity to align her vision with that of Pfizer’s leadership. She believes that the company’s commitment to AI will significantly impact patients' lives by accelerating breakthroughs in medicine and healthcare.

Her appointment at Pfizer follows other recent high-profile hires, including Andrew Baum as Chief Strategy and Innovation Officer and the announcement of Susan Rienow as the new Global Chief Marketing Officer. These appointments reflect Pfizer’s ongoing efforts to enhance its leadership team and drive innovation in the pharmaceutical sector.

As Pfizer continues to explore the potential of AI in drug development and patient care, Rodriguez-Hervas’s leadership will be crucial in guiding these efforts, ensuring the company remains at the forefront of technological advancements in healthcare.

Want more org charts? Sign up to The Org here!